Additionally, Gao et al. demonstrated that YBX1 underwent SIAH1-mediated ubiquitination at the lysine residue located at position 304, resulting in the enhanced sensitivity of epithelial ovarian cancer cells to cisplatin222. The gene discussed is YBX1; the disease is ovarian carcinoma.